TiO2 nanowired Cerebrolysin for neuroprotection in concussive head injury
Uppsala University, Uppland, Sweden
Our innovation shows that intravenous administration of TiO2 nanowired-tagged Cerebrolysin (Ever NeuroPharma, Austria) that is a balanced composition of several neurotrophic factors and active peptide fragments enhanced neuroprotection after concussive head injury (CHI) in rat model (5 ml/kg 1 to 2 h after CHI) as compared to normal cerebrolysin.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Concept
Technology Readiness Level: TRL 3
FIGURES OF MERIT
Value Proposition: I want some financial support to develop this strategy for treatment of heat injury effectively in military personnel for better results and to rehabilitate them most effectively that the available treatment so far.
Organization Type: Academic/Gov Lab
Showcase Booth #: 38M
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: None
Primary Sources of Funding: University, Other
Looking for: Both Funding and Development Partners